PHARMACEUTICAL COMPOSITION USING STRYPHNODENDRON EXTRACTS FOR TREATING HPV INFECTIONS

The present invention relates to the use of extracts, in particular alcoholic, hydroalcoholic and aqueous extracts of the bark, bast, stems and pod shells of the species Abarema cochliocarpos (Gomes) Barneby & Grimes and/or Stryphnodendron barbatiman, Stryphnodendron coriaceum Benth., S. diacolor Benth., S. pulcherrimum (Wildd) Hoch., Stryphnodendron adstríngens (Mart.) Coville, Stryphnodendron obovatum Benth., Stryphnodendron polyphyllum M. and Pithecellobium avaremotemo Mart., which are all popularly known in Portuguese under the name "barbatimão", used (as an adjuvant) for the treatment of human papilloma virus-related (HPV) infections and for the prevention of cervical cancer. La présente invention concerne l'utilisation d'extraits, et notamment d'extraits alcooliques, hydroalcooliques et aqueux, de l'écorce, du liber, des tiges et des enveloppes de graines des espèces Abarema cochliocarpos (Gomes) Barneby & Grimes et/ou Stryphnodendron barbatiman, Stryphnodendron coriaceum Benth., S. diacolor Benth., S. pulcherrimum (Wildd) Hoch., Stryphnodendron adstríngens (Mart.) Coville, Stryphnodendron obovatum Benth., Stryphnodendron polyphyllum M. et Pithecellobium avaremotemo Mart., toutes connues populairement en portugais sous le nom de "barbatimão", pour le traitement (comme adjuvant) des infections associées au papillomavirus humain (VPH) et pour la prévention du cancer cervical. A presente invenção refere-se à aplicação de extratos, principalmente alcoólicos, hidroalcoólicos e aquosos das cascas, entrecascas, dos caules e das cascas das vagens de Abarema cochliocarpos (Gomes) Barneby & Grimes e/ou Stryphnodendron barbatiman, Stryphnodendron coriaceum Benth., S. diacolor Benth., S. pulcherrimum (Wildd) Hoch., Stryphnodendron adstríngens (Mart.) Coville, Stryphnodendron obovatum Benth., Stryphnodendron polyphyllum M. e Pithecellobium avaremotemo Mart., todas conhecidas com nome popular de barbatimão utilizado para tratamento (como adjuvante) das infecções relacionados aos Papilomavírus humano (HPV) e para profilaxia do câncer cervical.